IN previous studies, pressor reactivity to several standardized noxious stimuli was evaluated quantitatively, and increased responsiveness was demonstrated in hypertensive as compared with normotensive subjects." 2 The stimuli employed in these studies included simple psychologic provocation as well as the cold pressor test and the intravenous injection of a small dose of angiotensin II. Differences in the physiologic mechanisms of response were suggested from examination of the influence of diabetes mellitus on pressor reactivity to these stimuli.2 Since alteration by hypotensive drugs of the blood pressure response to noxious stimuli represents a clinically important but usually undetermined pharmacologic function, evaluation of the effect of several of these agents also was undertaken. In an earlier study it was reported that chlorothiazide and reserpine, in their usual therapeutic doses in hypertensive patients, failed to diminish the degree of pressor response to several of the aforementioned stimuli, despite lowering of the basal pressure.3 The present study was designed to test the reactivity of hypertensive patients before and during therapy with two more potent hypotensive agents, guanethidine sulfate and alpha methyldopa. The data also were examined for information pertinent to the questions of the clinical pharmacology and mechanism of action of these compounds.
IN previous studies, pressor reactivity to several standardized noxious stimuli was evaluated quantitatively, and increased responsiveness was demonstrated in hypertensive as compared with normotensive subjects." 2 The stimuli employed in these studies included simple psychologic provocation as well as the cold pressor test and the intravenous injection of a small dose of angiotensin II. Differences in the physiologic mechanisms of response were suggested from examination of the influence of diabetes mellitus on pressor reactivity to these stimuli. 2 Since alteration by hypotensive drugs of the blood pressure response to noxious stimuli represents a clinically important but usually undetermined pharmacologic function, evaluation of the effect of several of these agents also was undertaken. In an earlier study it was reported that chlorothiazide and reserpine, in their usual therapeutic doses in hypertensive patients, failed to diminish the degree of pressor response to several of the aforementioned stimuli, despite lowering of the basal pressure.3 The present study was designed to test the reactivity of hypertensive patients before and during therapy with two more potent hypotensive agents, guanethidine sulfate and alpha methyldopa. The data also were examined for information pertinent to the questions of the clinical pharmacology and mechanism of action of these compounds. 
Methods and Materials
Twenty-eight studies were done in subjects with moderate to severe hypertensive vascular disease, before and during therapy. Thirteen were in patients receiving guanethidine sulfate and 15 in patients on alpha methyldopa. The severity of the hypertensive disease and the average dose and duration of therapy in each group are indicated in table 1.
Patients were either ambulatory and seen regularly in the Hypertension-Renal Clinic or were hospitalized on the Clinical Research Unit * of the Presbyterian-University Hospital. All were receiving the medications for therapeutic indications.
Four noxious stimuli that have been described in detail previously 1-3 were administered to study pressor responses. They consisted of (1) the intravenous injection of 10 ml. of normal saline during which the patient is asked "to count backwards from 100 as rapidly as possible" (saline); (2) a standard cold pressor test; (3) the reading of a confusing color chart (color); (4) the intravenous injection of 0.03 jgg./Kg. body weight of angiotensin II over a period of 1 minute. In the group of 13 patients receiving guanethidine sulfate, only the last eight were tested with angiotensin. Of the 15 on alpha methyldopa, one was not tested with angiotensin. The four tests were administered at 15-minute intervals after an initial rest period of 15 to 30 minutes.
The order of administration of the stimuli was the same in all subjects, as follows: saline, cold pressor, angiotensin, color. In most subjects, the first testing was before therapy. In a few, the first set of tests was performed while subjects were receiving medication and, in these instances, a minimum of 2 weeks was allowed to elapse before re-testing. Tests were done in the morning, usually with the patients in a fasting state, but at least 1 figure 1 (guanethidine sulfate group) and figure 2 (alpha methyldopa group). The declines in pretest baselines and erect blood pressures are also illustrated in these figures. The method of paired differences was used to test the significance of the changes in both pretest levels and responses. It is apparent that both drugs caused only a modest decline in the supine pretest baseline pressures. In fact, with guanethidine sulfate, the average fall was of questionable significance. The erect blood pressures, however, were lowered significantly with both compounds.
The effect of therapy on pressor responsiveness essentially was similar with both drugs. The most striking feature was the contrast between the cold pressor response, which was decreased markedly with therapy, and the angiotensin response, which was unaffected by guanethidine and indeed significantly increased, albeit a modest amount, in the subjects receiving alpha methyldopa. A dose-dependent relationship of the fall in cold pressor response was noted with alpha methyldopa; this was suggested by the data for guanethidine sulfate, but was not as clear-cut ( fig. 3) .
The patterns of the changes in pulse rate were similar to those for blood pressure. Pretest baseline rates declined during therapy * The median was determined rather than the mean because these are ratios and accordingly do not follow a normal distribution. patients receiving alpha methyldopa.8 As suggested in our report of angiotensin and cold pressor reactivity in normal and diabetic subjects,2 an elevation of the "A/CP ratio" above 2.0, although this is an empirically derived figure dependent on conducting both tests according to the described protocol, may serve clinically to indicate impairment of sympathetic innervation of peripheral vasculature.
A significant decline was noted in both the saline and color responses with guanethidine, and in the saline test only with alpha methyldopa. In the previous study with chlorothiazide and reserpine, these responses, as well as the cold pressor response, did not decline. 3 In diabetic subjects with sympathetic impairment, however, in whom the cold pressor response was decreased, responses to these psychological stimuli also were not diminished and it was proposed that they could operate alternatively through humoral or "angiotensin-like" mechanisms.2 The data in the present study, indicating that with the sympatholysis induced by these potent compounds the psychophysiologic responses were depressed, would suggest that our previous observation in diabetic subjects was dose dependent, i.e., a less complete sympathetic denervation was present in the diabetic subjects than in the present group of patients on drugs. On the other hand, the difference between the two groups could be interpreted as time dependent, i.e., alternative response pathways may represent a gradually developing adaptive mechanism to spontaneous acquisition of sympathetic impairment, and thus may be absent with the relatively acute sympatholysis produced by drugs. Such concepts, however, are inferred from hemodynamic measurements that are influenced by a variety of factors and remain speculative. The hypothesis that peripheral mechanisms alternative to the autonomic nervous system, such as the elaboration of vasoactive polypeptides, could mediate cardiovascular responsiveness, is attractive, but its exploration requires the development of technics for measuring the humoral biochemical changes acutely accompanying responses to noxious stimuli.
The study was not designed and the patients were not selected specifically to compare differences between the effects of guanethidine sulfate and alpha methyldopa, but several observations can be noted. Pharmacologically the two compounds act differently on the autonomic nervous system. Guanethidine sulfate appears to deplete norepinephrine stores or to interfere with norepinephrine release at peripheral sites, possibly by blocking acetylcholine.9 Alpha methyldopa theoretically could interfere with norepinephrine synthesis by competitive inhibition at the decarboxylase step. Some investigators have reported a decrease in the excretion of the urinary metabolite vanilmandelic acid,10 but others have not.11 12 Tissue depletion of norepinephrine occurs, but neither the persistence of this depletion nor the hypotensive effects of the compound correlate with the duration of decarboxylase inhibition.12 It has been suggested, therefore, that the amine metabolites of alpha methyldopa themselves are responsible directly for norepinephrine depletion.12 Alternatively, Dacty and Rand have argued that alpha methylnorepinephrine, itself a pressor material but less potent than norepinephrine, becomes a "false transmitter" after administration of alpha methyldopa and hence responses to sympathetic stimulation are dampened. 13 The situation remains uncertain as is emphasized by a comprehensive recent study of the metabolism of alpha methyldopa in man by Buhs and co-workers. The data of these investigators indicate no apparent correlation between the variations in the metabolic fate of the drug and its degree of hypotensive action.14 Clinically, however, the two drugs produced qualitatively similar effects in the present study, effects that demonstrate at least a functional sympatholysis. The effect of guanethidine sulfate on the pulse rate seemed more pronounced, a finding which may indicate that although both drugs deplete cardiac tissue of catecholamines,l. the clinical effect on the heart is more pronounced with guanethidine than with alpha methyldopa. Alpha methyldopa lowered the supine pressure to a greater extent than did guanethidine sulfate, which is in keeping with the impression that this drug has a greater potential to lower blood pressure by actually decreasing peripheral resistance.8 Nevertheless, as these observers, and others,'16 17 pointed out, an additional and quite significant postural hypotension is present, as usually occurs with drugs that are operationally sympatholytic, and is the result of fall in cardiac output in the erect position. The dose-dependent relationship of the depression of the cold pressor response with alpha methyldopa was indicative of increasing sympatholysis with increasing dosage.
The results, as did those with chlorothiazide and reserpine, 3 supine and impaired the pressor response to the cold pressor test. The pressor reactivity to intravenous angiotensin, however, persisted. Responses to psychophysiologic stimuli were decreased. The implications of these findings for both therapy and for understanding of physiologic mechanisms of pressor reactivity are discussed.
